Federal officials announced Ozempic, Wegovy and 13 other drugs are on a list of medications the government is targeting for Medicare price negotiations next year.

A modern-day renaissance man, jazz trumpeter and opera composer Terence Blanchard is an 8-time Grammy Award-winner whose film ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

The Centers for Medicare & Medicaid Services announced 15 new drugs it wants to lower the cost for, including popular, but ...

The U.S. government named 15 drugs that will be subject to the second round of price negotiations by Medicare, including ...

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide ...

The hugely popular medications Ozempic and Wegovy​, used for diabetes and weight loss, will be included in the next round of ...

The talks around drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

As weight-loss drugs like Ozempic become normalized solutions to over-eating habits, researchers at Pennington Biomedical ...

The governor also said she would work with other states to leverage their combined purchasing power to reduce the cost of the ...